-
Heidi to become “AI care partner”
Tuesday | Feb 24 2026LEADING clinical AI scribe Heidi has announced the launch of Heidi Evidence, a new clinical-grade research tool integrated directly into the Heidi platform.
-
Arrotex to market novel eye drops
Tuesday | Feb 24 2026ARROTEX Pharmaceuticals has entered into a licensing agreement with Taiwan-based Formosa Pharmaceuticals for exclusive rights to the commercialisation of an innovative ophthalmic suspension in Australia and NZ.
-
-
PD for Tue 24 Feb 2026
Tuesday | Feb 24 2026Sigma gains stake in Pharmx, med cannabis access framework “not fit-for-purpose”, new CEO for Mayne Pharma, and more
-
From awareness to action
Monday | Feb 23 2026SHINGLES Awareness Week is rebranding this year to Shingles Action Week, as a result of research showing that knowledge alone is not enough.
-
Improving meds management
Monday | Feb 23 2026RESEARCHERS at Monash University and Flinders University have released a new guide on how to establish and lead a quality improvement collaborative (QIC) that supports senior healthcare professionals, managers and leaders across healthcare settings looking to improve medication management practices.
-
J&J facing talc class action
Monday | Feb 23 2026AUSTRALIAN law firm Shine Lawyers has commenced a class action against Johnson & Johnson, alleging its talcum powder products were “defective, unfit for purpose and not of merchantable quality due to the potential to cause cancer”.
-
Passport to profit
Monday | Feb 23 2026THE ID Station biometric passport camera system provides ICAO-compliant passport photos that deliver high margin returns for pharmacy businesses.
-
Coffee with FIP
Monday | Feb 23 2026THE latest International Pharmaceutical Federation (FIP) podcast features the University of Sydney’s Assoc Prof Betty Chaar among guests discussing the ethical dimensions of pharmacist prescribing, including patient trust, privacy and managing conflicts of interest.
-
Freedom to be you
Monday | Feb 23 2026PHARMACY Choice provides banner-level support, buying power and marketing, while allowing full independence – see the cover page for more.
PARTNER SITES
to top